The Malaria Consortium shared the results of a study that tested the feasibility of co-implementing vitamin A supplementation (VAS) with a seasonal malaria chemoprevention (SMC) campaign in rural and urban settings in Bauchi State Nigeria. This 2021 study builds on the recommendations from an initial Implementation aims to develop strategies for available or new health interventions in order to improve access to, and the use of, these research study conducted in 2019. The study was co-designed with key stakeholders including the NMEP, the FMoH (the National Agency for Food and Drug Administration and Control; the Department of Planning Research and Statistics; and the Nutrition Division), the Bauchi State Malaria Elimination Programme and the State Primary Health Care Development Agency. Its aim was to inform new (i) A set of decisions or commitments to pursue courses of action aimed at achieving defined goals for improving health, stating or guidance and to answer questions about safety, Equity in the context of public health campaigns refers to providing high-quality interventions uniformly and in a fair and impartial manner to, feasibility in different settings, the cost of the integrated campaign, and target-setting.
Presenter: Dr. Olusola Oresanya, Senior Country Technical Coordinator, Malaria Consortium. View her bio here.
Malaria Consortium is a leading implementer of SMC in Nigeria, which has been recommended as a malaria prevention strategy for children 3–59 months since 2012. Please see a learning brief and advocacy brief developed from the project. Download slides below and view the Test & Learn session with Malaria Consortium to learn about actions you can consider for planning and implementing effective, equitable, and feasible health campaigns.